Nicolas Provost

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip et al. · Annals of Oncology · 2015 · 111 citations · Full text

Medicine, Oncology, Pharmacology +8

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study

Victor de Lédinghen, Vlad Ratziu, Xavier Causse et al. · Journal of Hepatology · 2006 · 75 citations

Medicine, Pathology, Hepatology +14

Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice

Klaus Seedorf, Csaba Weber, Cédric Vinson et al. · JHEP Reports · 2022 · 47 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Assessment of Age Modulated Vascular Inflammation in ApoE−/− Mice by USPIO-Enhanced Magnetic Resonance Imaging

Monica Sigovan, Amine Bessaad, Hasan Alsaid et al. · Investigative Radiology · 2010 · 42 citations

Medicine, Cardiology, Pathobiology +15

Low WSS Induces Intimal Thickening, while Large WSS Variation and Inflammation Induce Medial Thinning, in an Animal Model of Atherosclerosis

Antoine Millon, Monica Sigovan, Loïc Boussel et al. · PLoS ONE · 2015 · 39 citations · Full text

Medicine, Cardiology, Surgery +17